ILAG NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Intelligent Living Application Group Inc · Industrials · Building Products & Equipment

Open interactive chart View report data
Latest close 3.34 USD
0.3% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 1.1% above the Trend Line and sits at 17.3% of its 52-week range. The latest completed week returned 0.3%, after a -12.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal.

Setup score 20 out of 100
Latest Close 3.34 USD 7 Aug 2026
1W Return 0.3% latest completed week
4W Return -12.3% short-term follow-through
12W Return -19.7% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 0.0x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.3% Latest completed week; four-week move -12.3%. Indicator stack 33/35 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 47/100 31 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 1.1% above the Trend Line and sits at 17.3% of its 52-week range. The latest completed week returned 0.3%, after a -12.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.0x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1712-week average 0.25

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.17Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -12.3% over four weeks, -19.7% over 12 weeks, and -35.8% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W0.3%
4W-12.3%
12W-19.7%
26W30.5%
52W-35.8%
Active trend streak5 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.22Latest activity-pressure read.
Pressure change-140.2%Four-week change in activity pressure.
Leadership-29.35Latest relative-leadership reading.
RS change-27.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 79% Model confidence 74%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength57/100Blend of value, momentum, and quality. Underlying universe rank 44; rank 1 is best.
Value53/100Relative valuation strength. Underlying universe rank 48; rank 1 is best.
Quality51/100Profitability and accounting quality. Underlying universe rank 50; rank 1 is best.
Momentum53/100Medium-term price momentum. Underlying universe rank 48; rank 1 is best.
Growth53/100Revenue and earnings growth. Underlying universe rank 48; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-28.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
2.9%
Gross profit retained from each unit of revenue.
Operating margin
-428.9%
Operating profit retained from revenue.
Free-cash-flow margin
-53.5%
Free cash flow generated from revenue.
Return on invested capital
-230.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-6.1%
Net share repurchases relative to market value.
Shareholder yield
-6.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment47/100

Weighted news tone is neutral across 31 relevant articles.

0 positive · 25 neutral · 6 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-65.1%Distance below the 52-week high.
13-week volatility10.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+41.3%Week of 3 Apr.
Worst week-22.3%Week of 12 Jun.
Latest week+0.3%Week of 7 Aug.

Shape of recent returns

Strong gains11
Modest gains3
Flat weeks0
Modest losses3
Sharp losses9
Recent vol10.5%13-week weekly-return volatility.
Base vol12.4%52-week weekly-return volatility.
Up/down split27/24Count of positive and negative weeks in the 52-week window.
Average skew8.5% / -9.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape24/100

Trend, activity pressure, participation, and risk combine to a 24/100 tape read.

 Indicator analysis39/100

Latest 12-week confirmation: trend 5/12, activity pressure 10/12, relative leadership 0/12.

Activity pressure 0.17; No reversal markers Factors53/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 83 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment47/100

Weighted news tone is neutral across 31 relevant articles.

ILAG|Intelligent Living Application Group Inc|Price:3.310|Chg%:-0.020 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20263.34 USD0.3%3.30 USD6.02 USD-0.22-29.354.0KOn
31 Jul 20263.33 USD-3.5%3.33 USD6.07 USD-0.02-26.9410.0KOn
24 Jul 20263.45 USD-7.5%3.34 USD6.12 USD0.20-24.6649.3KOn
17 Jul 20263.73 USD-2.1%3.34 USD6.17 USD0.42-20.7049.1KOn
10 Jul 20263.81 USD9.2%3.33 USD6.22 USD0.54-23.11119.4KOn
3 Jul 20263.49 USD-5.4%3.37 USD6.27 USD0.55-29.09270.8KOff
26 Jun 20263.69 USD19.8%3.42 USD6.32 USD0.60-25.2483.5KOff
19 Jun 20263.08 USD13.2%3.46 USD6.37 USD0.63-41.051.5MOff
12 Jun 20262.72 USD-22.3%3.51 USD6.42 USD0.71-47.732.5MOff
5 Jun 20263.50 USD-6.9%3.58 USD6.47 USD0.87-32.165.5KOff
29 May 20263.76 USD0.3%3.62 USD6.52 USD0.93-31.089.4KOff
22 May 20263.75 USD-9.9%3.69 USD6.57 USD0.93-29.728.3KOff
15 May 20264.16 USD6.4%3.75 USD6.61 USD0.93-21.7149.2KOff
8 May 20263.91 USD4.0%3.82 USD6.66 USD0.84-26.948.7KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context